From In Turnaround Saga, Ignyta Nears Crucial Phase in Cancer Drug Trial:

Ignyta CEO Jonathan Lim

Ignyta CEO Jonathan Lim—

Ignyta CEO Jonathan Lim (Xconomy image by BVBigelow 2016)

Underwriters and Partners

Xconomy Insight

Sponsored · Video
The Importance of Early Planning for Biotechs & Engaging with a CRO for Molecule Development
A Fireside Chat with Medpace's Regulatory Affairs Director David Horton
Medpace

From Our Editors · Special Report
Xcelerating Life Sciences Boston: Special Report
Biopharma's Future in Digital Health

Sponsored · Special Report
As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future
Hyperinflation in rents is over
Hughes Marino

Xconomy on Demand

We offer a number of ways to subscribe for free!